Nutritional pharmacology and malignant disease: A therapeutic modality in patients with cancer
Authors:
- 1 May 1996
- journal article
- review article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 83 (5) , 608-619
Abstract
It is now established that certain nutrients have a significant effect on cellular metabolism and growth, tissue repair and regeneration, and modulation of host defences. So far, however, potential clinical benefits have been difficult to demonstrate. Nevertheless, the use of nutrients in combinations seems to have promise and may be associated with a reduction in infectious complications and length of hospital stay. Nutritional pharmacology in the future may be able to improve tumour response to chemotherapy and may minimize the metabolic effect of cachexia.Keywords
This publication has 99 references indexed in Scilit:
- Dietary supplementation with L-arginine in patients with breast cancer (> 4 cm) receiving multimodality treatment: report of a feasibility studyBritish Journal of Cancer, 1994
- Stimulation of human breast cancers by dietary l-arginineClinical Science, 1992
- Role of Arginine in Trauma, Sepsis, and ImmunityJournal of Parenteral and Enteral Nutrition, 1990
- Biosynthesis of nitric oxide from l-arginineBiochemical Pharmacology, 1989
- Immune and Metabolic Effects of Arginine in the Surgical PatientAnnals of Surgery, 1988
- Arginine Needs, Physiological State and Usual Diets. A ReevaluationThe Journal of Nutrition, 1986
- Polyamine metabolism and functionAmerican Journal of Physiology-Cell Physiology, 1982
- Nitrogen retention in rats fed on diets enriched with arginine and glycineBritish Journal of Nutrition, 1977
- In vivo synthesis and utilization of arginine in the ratAmerican Journal of Physiology-Legacy Content, 1972
- Amino Acid Requirements of Children: Minimal Needs of Tryptophan, Arginine and Histidine Based on Nitrogen Balance MethodThe Journal of Nutrition, 1963